These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31788260)

  • 21. Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.
    Chen SY; Ravindran G; Zhang Q; Kisely S; Siskind D
    CNS Drugs; 2019 Mar; 33(3):225-238. PubMed ID: 30758782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea.
    Rajagopal V; Sundaresan L; Rajkumar AP; Chittybabu C; Kuruvilla A; Srivastava A; Balasubramanian P; Jacob KS; Jacob M
    Psychiatr Genet; 2014 Dec; 24(6):273-6. PubMed ID: 25304228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea.
    Leung JG; Kutzke JL; Morgan RJ; Schak KM
    Ment Health Clin; 2020 Jan; 10(1):34-37. PubMed ID: 31942277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual atropine drops for the treatment of pediatric sialorrhea.
    Rapoport A
    J Pain Symptom Manage; 2010 Nov; 40(5):783-8. PubMed ID: 20541902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-induced sialorrhea: pathophysiology and management strategies.
    Praharaj SK; Arora M; Gandotra S
    Psychopharmacology (Berl); 2006 Apr; 185(3):265-73. PubMed ID: 16514524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between
    Ishikawa S; Kobayashi M; Hashimoto N; Mikami H; Tanimura A; Narumi K; Furugen A; Kusumi I; Iseki K
    J Pharmacol Exp Ther; 2020 Nov; 375(2):376-384. PubMed ID: 32862145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of atropine eye drops for clozapine induced hypersalivation.
    Comley C; Galletly C; Ash D
    Aust N Z J Psychiatry; 2000 Dec; 34(6):1033-4. PubMed ID: 11127617
    [No Abstract]   [Full Text] [Related]  

  • 28. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.
    Kahl KG; Hagenah J; Zapf S; Trillenberg P; Klein C; Lencer R
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):229-30. PubMed ID: 14747903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
    Kahl KG; Trillenberg P; Kordon A; Lencer R; Klein C; Hagenah J
    Nervenarzt; 2005 Feb; 76(2):205-8. PubMed ID: 15448913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amisulpride for clozapine induced sialorrhea.
    Aggarwal A; Sharma DD
    Psychopharmacol Bull; 2009; 42(4):69-71. PubMed ID: 20581795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atropine-induced toxicity after off-label sublingual administration of eyedrop for sialorrhoea treatment in neurological disabled patients.
    Michelon H; Larabi IA; Lemoine J; Alvarez JC; Genevée A; Lillo-Lelouet A; Azouvi P; Lefèvre-Dognin C; Paquereau J
    Br J Clin Pharmacol; 2021 Aug; 87(8):3364-3369. PubMed ID: 33521988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment options for drug-induced sialorrhea: Prescribing guidelines].
    Cuvelier E; Gressier B; Fovet T; Simon N; Décaudin B; Amad A
    Encephale; 2022 Dec; 48(6):700-711. PubMed ID: 35989107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
    Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea.
    Leung JG; Puri NV; Jacobson MJ
    Ann Pharmacother; 2011 Sep; 45(9):e45. PubMed ID: 21852588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review.
    Petkus KD; Noritz G; Glader L
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histidine Metabolic Pathway Contributes to Clozapine-Induced Sialorrhea Based on Nontargeted Metabolomics.
    Zhang K; Wu S; Wang Y; Zhou Y; Guo J; Xiao A; Ye J; Wu B; Li S; Zhu F; Li Z; Yu L
    Neuropsychobiology; 2023; 82(5):271-286. PubMed ID: 37640020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
    Calderon J; Rubin E; Sobota WL
    Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine-induced hypersalivation: a review of treatment strategies.
    Sockalingam S; Shammi C; Remington G
    Can J Psychiatry; 2007 Jun; 52(6):377-84. PubMed ID: 17696024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.